Valneva appoints Perry Celentano as interim COO, David Lawrence as acting CFO January 11, 2021 SAINT-HERBLAIN: Valneva SE a specialty vaccine company focused on prevention against diseases with major unmet needs, has appointed Perry Celentano as Chief Operating Officer…
Nanobiotix announces key development milestones for 2021 after successful Nasdaq IPO January 8, 2021 PARIS: Nanobiotix announced its global development plan for 2021 and beyond. Nanobiotix is a clinical-stage biotechnology company focused on developing first-in-class product candidates that…
Celyad Oncology signs $40 million equity purchase agreement with Lincoln Park Capital January 7, 2021 BRUSSELS: Celyad Oncology SA has entered into a committed equity purchase agreement for up to $40 million with Lincoln Park Capital Fund LLC, a…
Advicenne hires Peter Meeus as Chief Executive Officer January 7, 2021 PARIS: Advicenne announced the appointment of Peter Meeus as Chief Executive Officer of Advicenne, effective February 15, 2021. Dr. André Ulmann, who has been…
Heijmans sells 95 rental apartments in Noorderhaven project in Zutphen January 7, 2021 AMSTERDAM: Heijmans has reached agreement with housing corporation Habion on the sale of ground and the realisation of 95 rental apartments in the Noorderhaven…
Total will develop the LNG market in Benin July 25, 2019 PARIS–(BUSINESS WIRE)– Total, the Republic of Benin and the Société Béninoise d’Energie Electrique (SBEE) have signed the Gas Supply Agreement and the Host Government…
Lonza expands Bioconjugation facility and announces approval of third commercial ADC July 24, 2019 BASEL, SWITZERLAND: Lonza has announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a…